Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 5, 2014, Pages 562-568

  Tanawuttiwat, Tanyanan ^a   Garisto, Juan D ^a   Salow, Arturo ^a   Glad, Joann M ^b   Szymkiewicz, Steve ^b   Saltzman, Heath E ^c   Kutalek, Steven P ^c   Carrillo, Roger G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b ZOLL Medical Corporation   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

ICD removal; sudden cardiac death; wearable cardioverter defibrillator

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; DATA ANALYSIS; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; FEMALE; HEALTH CENTER; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTPATIENT; PATIENT COMPLIANCE; PATIENT SAFETY; RETROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; TREATMENT DURATION; TREATMENT OUTCOME; VEIN THROMBOSIS; WEARABLE CARDIOVERTER DEFIBRILLATOR; AMBULATORY CARE; AMBULATORY MONITORING; CARDIOVERSION; CLASSIFICATION; DEATH, SUDDEN, CARDIAC; DEVICES; EPIDEMIOLOGY; INCIDENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AMBULATORY CARE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MONITORING, AMBULATORY; OUTPATIENTS; PENNSYLVANIA; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84899658950     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12319     Document Type: Article

References (21)

1. Hayes DL, Furman S,. Cardiac pacing: How it started, where we are, where we are going. Heart Rhythm 2004; 1 (5 Suppl.): 115C-126C. (Pubitemid 40309729)
2. Goldberger JJ, Passman R,. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: The results are not shocking. J Am Coll Cardiol 2009; 54: 2001-2005.
3. Olshansky B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, et al. Where patients with mild to moderate heart failure die: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007; 153: 1089-1094. (Pubitemid 46809836)
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
5. Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, et al. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 2003; 14: 940-948. (Pubitemid 37115157)
6. Voigt A, Shalaby A, Saba S,. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006; 48: 590-591. (Pubitemid 44093958)
7. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, et al. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010; 121: 458-477.
8. Voigt A, Shalaby A, Saba S,. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: Temporal trends and causative insights. Pacing Clin Electrophysiol 2010; 33: 414-419.
9. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49: 1851-1859. (Pubitemid 46661104)
10. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, Fraser TG, et al. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes. Heart Rhythm 2010; 7: 1043-1047.
11. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007; 116: 1349-1355. (Pubitemid 47417560)
12. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH, 3rd, Epstein LM, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: This document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009; 6: 1085-1104.
13. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Mansoudi FA, et al. A summary of the update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. J Am Dent Assoc. 2011; 142: 159-165.
14. Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, Mahon N, et al. Contemporary management of and outcomes from cardiac device related infections. Europace 2010; 12: 64-70.
15. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008; 83: 46-53.
16. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM,. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133: 604-608.
17. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacet S, et al. Systemic infection related to endocarditis on pacemaker leads: Clinical presentation and management. Circulation 1997; 95: 2098-2107. (Pubitemid 27184278)
18. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, Bors V, et al. Pacemaker infective endocarditis. Am J Cardiol 1998; 82: 480-484. (Pubitemid 28389947)
19. Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD, Tchou PJ,. Aggregate national experience with the wearable cardioverter- defibrillator: Event rates, compliance, and survival. J Am Coll Cardiol 2010; 56: 194-203.
20. Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: Results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004; 27: 4-9. (Pubitemid 38130738)
21. Dillon KA, Szymkiewicz SJ, Kaib TE,. Evaluation of the effectiveness of a wearable cardioverter defibrillator detection algorithm. J Electrocardiol 2010; 43: 63-67.